Clinical trials recruiting in Arzignano, Italy
3
Recruiting trials
7
Conditions
Phase breakdown
Phase 3 2Not applicable 1
Conditions recruiting in Arzignano, Italy
| Condition | Trials |
|---|---|
| Atherosclerotic Cardiovascular Disease | 1 |
| Heart Failure | 1 |
| Heart Failure With Reduced Ejection Fraction | 1 |
| High cholesterol | 1 |
| Hypercholesterolemia | 1 |
| Obesity | 1 |
| Overweight | 1 |
Recruiting trials in Arzignano, Italy
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Common questions
How many clinical trials are recruiting in Arzignano, Italy?
3 recruiting trials have at least one study site in Arzignano, Italy.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.